Sign in

Lost your password?
(close)

Ipsen Poland

Last updated: 13.02.2014

Address: 00-867 Warszawa
al. Jana Pawła II 29

Tel: 22 653 68 00

Web: http://www.ipsen.pl/

Company description

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 contribute to the discovery and development of innovative drugs for patient care.
Ipsen’s research & development (R&D) centers and its peptide & protein engineering platform give the Group a strong competitive edge. In 2009, R&D expenditure totaled close to €200 million, representing nearly 20% of Group sales.
Ipsen’s shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the “Service de Règlement Différé” (“SRD”). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the over-the-counter market in the United States under the symbol IPSEY.

Facts and figures in Poland:
Employment 30
Annual Turnover 80,000,000 zł.
Founded 1996

Products and services

Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and on primary care drugs. This strategy is supported by an active policy of partnerships.

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here